Singapore-based firm Biosyngen opens new manufacturing facility, set to hire 200 people

News Snapshot:

SINGAPORE - Singapore-based cell therapy company Biosyngen is looking to hire about 200 people in the next three to five years to staff its newly opened cell manufacturing facility at 5 Tai Seng Avenue. Roles include those in research and development, with expertise in areas such as cell therapy research, clinical operations, manufacturing, and quality assurance, Mr Isaac Chow, Biosyngen’s chief business officer, told The Straits Times at the opening of the new facility on Wednesday. The 1,500 sq m facility is designed for manufacturing immunotherapy drugs for patients, clinicians and hospitals internationally. Immunotherapy is a type of cancer treatment...